Skip to Main Content

Paper Details

A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor.
Clin Cancer Res
13
2019
Author NameAffiliation
Jonathan K KillianCenter for Cancer Research, National Cancer Institute
Jonathan K KillianCenter for Cancer Research, National Cancer Institute
Paul S MeltzerCenter for Cancer Research, National Cancer Institute
Paul S MeltzerCenter for Cancer Research, National Cancer Institute
William Marston LinehanCenter for Cancer Research, National Cancer Institute
Markku MiettinenCenter for Cancer Research, National Cancer Institute
Markku MiettinenCenter for Cancer Research, National Cancer Institute
Seth M SteinbergOffice of the Clinical Director, National Cancer Institute, Center for Cancer Research
Seth M SteinbergOffice of the Clinical Director, National Cancer Institute, Center for Cancer Research
Lee J HelmanCenter for Cancer Research, National Cancer Institute
Lee J HelmanCenter for Cancer Research, National Cancer Institute
Brigitte C WidemannCenter for Cancer Research, National Cancer Institute
  • 1 - 12

Datasets